MBX

NASD MBX Biosciences, Inc.
Sep 30, 2026 · 6:57 AM ET LAST TRADE Market Closed

$58.50 ↑ +0.75 (+1.30%) Trading Up from the previous close of $57.75

YTD change
+85.48%
vs 20-day SMA
-2.89%
vs 200-day SMA
+35.84%

Price ranges

Previous day
$56.55 $58.24
open $57.27 close $57.75
+$0.48 (+0.84%)
Today
$0.00 $0.00
$58.50
Past week
$52.32 $61.98
from $61.98 now $58.50
-$3.48 (-5.61%)
Past month
$52.32 $65.00
from $61.60 now $58.50
-$3.10 (-5.03%)
This year
$26.14 $72.64
from $31.54 now $58.50
+$26.96 (+85.48%)

Price & Performance

+30.83 (+114.52%) / 6M

$23.42$40.35$57.27$74.20Mar 30Jun 30Sep 29

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 19.5% away from all-time highs of $72.64
  • MBX is up 85% since the beginning of the year
  • MBX is up 234% over the past 12 months
  • MBX is down 5% over the past 1 month
  • 10% of all MBX investors are betting against MBX

MBX reads very good: price sits above one of the two key moving averages, the 12-month move is +230.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.78
Earnings momentum +6.0% Quarterly EPS growth
Quarterly change +6.0%

Valuation

P/E ratio N/A
Enterprise value $2.3B
Beta 0.04

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$418.6M
Debt$3.3K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $2.8B

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,184.63 -0.01%
JNJ Johnson & Johnson $267.57 -1.61%
ABBV AbbVie, Inc. $263.29 -1.12%
MRK Merck & Co., Inc. $149.28 +0.40%
RHHVF Roche Holding Ltd $431.56 -2.94%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.